Alnylam Pharmaceuticals, Inc. (ALNY)

286.98 -6.47 (-2.20%) USD  |  NASDAQ  |  May 15, 16:00
286.73 -0.25 (-0.09%) After-Hours: 20:00
More

Alnylam Pharmaceuticals EV to EBIT

EV to EBIT Chart

View EV to EBIT for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to EBIT Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to EBIT Range, Past 5 Years

View EV to EBIT Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to EBIT Benchmarks

View EV to EBIT Benchmarks
Start Trial
Aldeyra Therapeutics, Inc. --
Ionis Pharmaceuticals, Inc. --
Gilead Sciences, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade

EV to EBIT Related Metrics

EV to CFO Upgrade
EV to EBITDA Upgrade
EV to Revenues Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade